PSNL Personalis, Inc.

NASDAQ
$15.82

Personalis, Inc. (PSNL) is expected to report earnings on November 9, 2026, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of +17.7% since its last earnings release on August 4, 2026.

Personalis Missed Consensus Estimates
Tuesday, August 4, 2026 · 4:01 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 4:00 PM ET
Earnings Whisper
-
vs -
Rev est $23.3M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $16.19

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Personalis, Inc.

Personalis, Inc. is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency, and quality.

Sector

Healthcare

Industry

Medical Labs & Research

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.